Gender does not influence event-free survival in patients with ischaemic heart disease undergoing non-emergency coronary angiography. A single centre analysis

Kardiologia Polska

Volumn 65, Issue 5, 2007, Pages 475-484

  Jankowski, Piotr ^a   Kawecka Jaszcz, Kalina ^a   Czarnecka, Danuta ^a   Bryniarski, Leszek ^a   Brzozowska Kiszka, Małgorzata ^a   Kić Wilk, Beata ^a   Dymek, Grzegorz ^a   Kopacz, Ewa ^a   Królikowski, Tadeusz ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cardiovascular risk; Coronary artery disease; Gender; Quality of medical care

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; ORAL ANTIDIABETIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ARREST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PROBABILITY; SEX DIFFERENCE; STROKE;

EID: 34250766270     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anand SS, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol 2005; 46: 1845-51.
2. Fang J, Alderman MH. Gender differences of revascularization in patients with acute myocardial infarction. Am J Cardiol 2006; 97: 1722-6.
3. Janion M, Polewczyk A, Sielski J, et al. Odmienno?ci przebiegu choroby niedokrwiennej serca u kobiet. Kardiol Pol 2006; 64: 628-36.
4. Roeters van Lennep JE, Zwinderman AH, Roeters van Lennep HW, et al. Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome. Eur Heart J 2000; 21: 911-8.
5. Ben-Ami T, Gilutz H, Porath A, et al. No gender difference in the clinical management and outcome of unstable angina. Isr Med Assoc J 2005; 7: 228-32.
6. Wilczek K, Poloński L, Ga̧sior M, et al. Kobiety-mȩżczyźni. Czy to samo zawsze znaczy tak samo? Wstȩpna analiza danych ze Śla̧ska z Ogólnopolskiego rejestru ostrych zespołów wieńcowych PL-ACS na Śla̧sku. Kardiol Pol 2005; 62: I60-I66.
7. Daly CA, De Stavola B, Sendon JL, et al. Predicting prognosis in stable angina -results from the Euro heart survey of stable angina: prospective observational study. BMJ 2006; 332: 262-7.
8. Daly C, Clemens F, Lopez Sendon JL, et al. Gender Differences in the Management and Clinical Outcome of Stable Angina. Circulation 2006; 113: 490-8.
9. Kosuge M, Kimura K, Kojima S, et al. Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. Circ J 2006; 70: 217-21.
10. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999; 341: 226-32.
11. Rosengren A, Spetz CL, Koster M, et al. Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register. Eur Heart J 2001; 22: 314-22.
12. Hasdai D, Porter A, Rosengren A, et al. Effect of gender on outcomes of acute coronary syndromes. Am J Cardiol 2003; 91: 1466-9.
13. Frazier CG, Shah SH, Armstrong PW, et al. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials. Am Heart J 2005; 150: 1260-7.
14. Szygula-Jurkiewicz B, Wilczek K, Zembala M, et al. Obserwacja 6-miesiȩczna i czynniki ryzyka zgonu u 458 chorych z ostrymi zespołami wieńcowymi bez przetrwałego uniesienia odcinka ST poddanych wczesnej strategii inwazyjnej. Pol Arch Med Wewn 2004; 112: 1459-66.
15. Janion M. Myocardial infarction in women. Gender-related differences in clinical course and 6 year long term follow-up. Kardiol Pol 1999; 51: 305-14.
16. Kochman W, Prokopczuk P, Nowak K, et al. Acute myocardial infarction in women treated with primary coronary angioplasty. Analysis of in-hospital results. Folia Cardiol 2002; 9: 513-20.
17. Szygula-Jurkiewicz B, Wojnicz R, Trzeciak P, et al. Charakterystyka kliniczna, wyniki leczenia oraz czynniki wpływaja̧ce na śmiertelność wewna̧trzszpitalna̧ u pacjentów z ostrymi zespołami wieńcowymi bez przetrwałego uniesienia odcinka ST poddanych wczesnej strategii inwazyjnej. Przegl Lek 2005; 62: 265-9.
18. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999; 33: 1756-824.
19. Elkoustaf RA, Mamkin I, Mather JF, et al. Comparison of results of percutaneous coronary intervention for non-ST-elevation acute myocardial infarction or unstable angina pectoris in men versus women. Am J Cardiol 2006; 98: 182-6.
20. Kawecka-Jaszcz K, Jankowski P, Paja̧k A, et al. Wtórna prewencja choroby niedokrwiennej serca u kobiet. Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca. Folia Cardiol 2001; 8: D61-D67.
21. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109: 672-93.
22. Lansky AJ, Hochman JS, Ward PA, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 2005; 111: 940-53.
23. Ghali WA, Faris PD, Galbraith PD, et al. Sex differences in access to coronary revascularization after cardiac catheterization: importance of detailed clinical data. Ann Intern Med 2002; 136: 723-32.
24. De Bacquer D, De Backer G, Ostor E, et al. Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort. Eur J Cardiovasc Prev Rehabil 2003; 10: 289-95.
25. Johnson BD, Shaw LJ, Buchthal SD, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 2993-9.
26. Lenzen MJ, Boersma E, Bertrand ME, et al. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J 2005; 26: 1169-79.
27. Gil R, Pawłowski T. Analiza postȩpowania diagnostycznego i terapeutycznego u kobiet z choroba̧ wieńcowa̧ w okresie 1994-1999. Doświadczenia w?asne. Kardiol Pol 2000; 52 (Supl. III): 80-3.
28. Kawecka-Jaszcz K, Jankowski P, Paja̧k A, et al. Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca. Czȩś ć II: Wtórna prewencja choroby niedokrwiennej serca w okresie hospitalizacji. Przegl Lek 2001; 58: 956-63.
29. Paja̧k A, Kawecka-Jaszcz K, Jankowski P, et al. Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca. Porównanie realizacji wtórnej prewencji choroby niedokrwiennej serca w okresie hospitalizacji w latach 1996/97 i 1998/99. Przegl Lek 2003; 60: 136-41.